Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020193864 - PREGABALIN FORMULATIONS AND USE THEREOF

Publication Number WO/2020/193864
Publication Date 01.10.2020
International Application No. PCT/FI2020/050193
International Filing Date 26.03.2020
IPC
A61K 9/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
A61K 9/08 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
08Solutions
CPC
A61K 9/0056
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
0053Mouth and digestive tract, i.e. intraoral and peroral administration
0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
A61K 9/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
08Solutions
Applicants
  • ORION CORPORATION [FI]/[FI]
Inventors
  • HUHTINEN, Mirja
  • LAMMINEN, Terttu
  • SALMIA, Jukka
  • TERVAPURO, Johanna
  • VERCRUYSSE, Jurgen
Agents
  • ORION CORPORATION
Priority Data
2019522626.03.2019FI
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) PREGABALIN FORMULATIONS AND USE THEREOF
(FR) FORMULATIONS DE PRÉGABALINE ET LEUR UTILISATION
Abstract
(EN)
The invention relates to a pharmaceutical composition in the form of an orally deliverable liquid composition comprising pregabalin as an active ingredient and to the use thereof in the treatment and prevention of transportation and veterinary visit anxiety and fear in companion animals, such as cats. The composition is stable, well palatable to animals and can be easily administered by the pet owner.
(FR)
L'invention porte sur une composition pharmaceutique sous la forme d'une composition liquide administrable par voie orale comprenant de la prégabaline comme principe actif et son utilisation dans le traitement et la prévention de l'anxiété et de la peur liées au transport et aux visites vétérinaires chez les animaux de compagnie tels que les chats. La composition est stable, appétente pour les animaux et peut être facilement administrée par le propriétaire de l'animal.
Latest bibliographic data on file with the International Bureau